Rhabdomyosarcoma treated with chemotherapy during the third trimester

Obstetrics and Gynecology

Volumn 89, Issue 5 II SUPPL., 1997, Pages 828-831

  Martin, Dibe ^a   Winter, Stuart S ^b   Gardner, Michael O ^b   Nicklaus, Pamela ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; MESNA; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER STAGING; CASE REPORT; FEMALE; FETUS DEATH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; MUTAGENICITY; PRIORITY JOURNAL; REMISSION; RHABDOMYOSARCOMA; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME;

EID: 0030998107     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00034-3     Document Type: Article

References (18)

1. Cunningham FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC. Williams obstetrics. 19th ed. Norwalk, Connecticut: Appleton and Lange, 1993.
2. Pappo AS, Shapiro DN, Christ WM, Mauer HM. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 1995;13: 2123-39.
3. Tsokos M, Webber BL, Parham DM, Wesley RA, Miser A, Miser JS, et al. Rhabdomyosarcoma: A new classification scheme related to prognosis. Arch Pathol Lab Med 1992;116:847-55.
4. Crist WM, Garnsey L, Beltangady MS, Gehan F, Ruymann F, Webber B, et al. Prognosis for the children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II. J Clin Oncol 1990;8:443-52.
5. Prestidge BR, Donaldson SS. Treatment results of adults with childhood tumors: A 20 year experience. Int J Radiat Oncol Biol Phys 1989;17:507-14.
6. O'Day MP, Nielsen P, Al-Bozom I, Wilkins IA. Orbital rhabdomyosarcoma metastatic to the placenta. Am J Obstet Gynecol 1994;171:1382-3.
7. Rodary C, Gehan K, Flamant F, Treuner J, Carli M, Auquier A, et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcomas in children: A report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol 1991;19:89-95.
8. Kushner BH, Cheung N. Cyclophosphamide versus ifosfamide in paediatric oncology. Lancet 1990;336:253-4.
9. Maurer HM, Moon T, Donaldson M, Fernandez C, Gehan BA, Hammond D, et al. The Intergroup Rhabdomyosarcoma Study: A preliminary report. Cancer 1977;40:2015-26.
10. Maurer HM, Geham RA, Beltangady M, Crist W, Dickman PS, Donaldson SS, et al. The Intergroup Rhabdomyosarcoma Study II. Cancer 1993;71:1904-22.
11. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, et al. The Intergroup Rhabdomyosarcoma Study III. J Clin Oncol 1995;13:610-30.
12. DeVita VT, Hellman S, Rosenberg SA. Cancer principles and practice of oncology. Vol. 2. Philadelphia: JB Lippincott, 1993.
13. Friedmann I, Osborn DA. Pathology of granulomas and neoplasms of the nose and paranasal sinuses. Edinburgh: Churchill Livingstone, 1982.
14. Lloyd RV, Hajdu SI, Knapper WH. Embryonal rhabdomyosarcoma in adults. Cancer 1983;51:557-65.
15. De Jong ASH, Van Kesssle-Van Ark M, Albus Lutter ChE. Pleomorphic rhabdomyosarcoma in adults: Immunohistochemistry as a tool for its diagnosis. Hum Pathol 1987;18:298-303.
16. La Quaglia MP, Heller G, Ghavimi F, Casper ES, Vlamis V, Hajacu S, et al. The effect of age at diagnosis on outcome in rhabdomyosarcoma. Cancer 1994;73:109-17.
17. Callender TA, Weber SR, Janjan N, Benjamin R, Zaher M, Wolf P, et al. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg 1995;112:252-7.
18. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Baltimore: Williams & Wilkins, 1994.